Expression von Proteinen der Cadherin- und Catenin-Proteinfamilie bei juvenilen Angiofibromen

Hintergrund: Methode: Ergebnisse: Schlussfolgerungen: Background: Methods: Results: Conclusions:

[1]  E. Fearon,et al.  Cadherin and catenin alterations in human cancer , 2002, Genes, chromosomes & cancer.

[2]  E. Wilson,et al.  Liganded Androgen Receptor Interaction with β-Catenin , 2002, The Journal of Biological Chemistry.

[3]  P. Plinkert,et al.  Die vaskuläre Komponente: Gedanken zur Entstehung des Angiofibroms , 2002 .

[4]  D. Longo,et al.  Linking β-Catenin to Androgen-signaling Pathway* , 2002, The Journal of Biological Chemistry.

[5]  E. Montgomery,et al.  Frequent β-Catenin Mutations in Juvenile Nasopharyngeal Angiofibromas , 2001 .

[6]  B. Schick,et al.  Radiological findings in angiofibroma , 2000, Acta radiologica.

[7]  H. Stammberger,et al.  Nasopharyngeal angiofibroma: an APC-gene-associated tumor? , 2000, Human pathology.

[8]  C. Cohen,et al.  Immunolocalization of activated transforming growth factor beta1 in juvenile nasopharyngeal angiofibroma. , 2000, Archives of otolaryngology--head & neck surgery.

[9]  H. Stammberger,et al.  Nasopharyngeal Angiofibroma: True Neoplasm or Vascular Malformation? , 2000, Advances in anatomic pathology.

[10]  Sabine Tejpar,et al.  Predominance of beta-catenin mutations and beta-catenin dysregulation in sporadic aggressive fibromatosis (desmoid tumor) , 1999, Oncogene.

[11]  Keith R. Johnson,et al.  N-Cadherin Promotes Motility in Human Breast Cancer Cells Regardless of Their E-Cadherin Expression , 1999, The Journal of cell biology.

[12]  P. Vogt,et al.  Nuclear endpoint of Wnt signaling: neoplastic transformation induced by transactivating lymphoid-enhancing factor 1. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[13]  A. Gown,et al.  Expression of androgen receptors in nasopharyngeal angiofibroma: an immunohistochemical study of 24 cases. , 1998, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[14]  Anthony E. Reeve,et al.  E-cadherin germline mutations in familial gastric cancer , 1998, Nature.

[15]  W. Nelson,et al.  Cadherins, catenins and APC protein: interplay between cytoskeletal complexes and signaling pathways. , 1997, Current opinion in cell biology.

[16]  T. Carey,et al.  Expression of N-cadherin by human squamous carcinoma cells induces a scattered fibroblastic phenotype with disrupted cell-cell adhesion , 1996, The Journal of cell biology.

[17]  P. Paul,et al.  Juvenile Nasopharyngeal Angiofibroma and Familial Adenomatous Polyposis: An Association? , 1995, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[18]  G. Petersen,et al.  Nasopharyngeal angiofibroma in patients with familial adenomatous polyposis. , 1993, Gastroenterology.

[19]  G. Gates,et al.  Flutamide‐induced regression of angiofibroma , 1992, The Laryngoscope.

[20]  T. Brabletz,et al.  Beta-catenin and the morphogenesis of colorectal cancer. , 2002, Virchows Archiv : an international journal of pathology.

[21]  B. Henderson,et al.  Lymphoid Enhancer Factor-1 Blocks APC-mediated Nuclear Export and Degradation of β-catenin : Regulation by Histone Deacetylase 1 , 2002 .

[22]  H. Moses,et al.  Transforming growth factor-beta1 mediates epithelial to mesenchymal transdifferentiation through a RhoA-dependent mechanism. , 2001, Molecular biology of the cell.

[23]  Kathleen R. Cho,et al.  g -Catenin is regulated by the APC tumor suppressor and its oncogenic activity is distinct from that of b -catenin , 2000 .